Notify me when Mayur Ian Somaiya files a new Insider Trading report.
⭐ Subscribe ⭐| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| NAMS, NAMSW | NewAmsterdam Pharma Co N.V. | Chief Financial Officer | $1,973,311 | -$3,430,791 | -63% | 20 Jan 2026 |
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|